40 hours in ten patients, each with acute or chronic hypoxemia (or both) and in two normal volunteers. One other patient was followed at home up to 2,000 hours. The final concentration of oxygen in the inhaled gas (F1o2) was checked by analysis of oxygen within the oro pharynx when using the nasal cannulae and within the mask and in-line when using Venturi masks of oxygen concentrations of 24 to 40 percent. We demonstrated that oxygen could be supplied dependably via the ma chine, but only according to specific guidelines. The characteristics of this type of machine, as a result of Its flow-dependent ability to concentrate oxygen, are such T reatment of the nonhospitalized hypoxemic am bulatory patient involves the employment of a device for administration of oxygen outside the hos pital. Previous approaches to this problem have in corporated various sizes of cylinders with oxygen in eithergas or liquidform and solidsubstances that liberated oxygen.13Cylindersmay be bulky and have a finite capacity, aside from the hazards of fire and explosion. The systems using liquids and solids for treatment at home may be inconvenient because some lackmobility.
Recently, some oxygen â€oe¿ enrichersâ€• or â€oe¿ concen tratorsâ€•4have been developed that separate oxygen from room air using the principle of extraction either by a â€oe¿ molecular sieveâ€• or by membrane separation of gases. The â€oe¿ sieveâ€• is a complex inorganic silicate that has the ability to filter out nitrogenfrom room air, leaving gas with a higher concentration of oxygen. One such oxygen enricher (DeVilbiss) was evalu ated for accuracy, reproducibility, variable response with ancillary devices for administration of oxygen, and feasibility for prolonged use.
MATERIALS @mMETHODS
The oxygenenricher (DeVilbiss DeVo,) was tested using nasal cannulae (Hudson Corp) and Venturi masks in 24, 28.
31, 35, and 40 percent models (Inspiron Accurox). Analysis of oxygen concentrations was performedusing a polaro graphicoxygenanalyzer witha rapidresponse (Ohio Med ical Corp). When measuring the concentration of oxygen within the Venturi mask, the external sensor was placed inside the mask at the point of inflow (Fig 1) . When measuring the concentrations of oxygen in-line with Venturi masks, analysis was performed using the external sensor fitted with a T-adapter with an outer diameter of 22 mm (Fig 2) .
The two methods were used in order to compare concentra tions of oxygen and assure accuracy. When measuring oxygen usingthecannulawithinthenares, analysis was performed with the external sensor and a tubing adapter with an outer diameter of Ii inch. To measure the concentration of oxygen in the inspired gas (Flo,) accurately when subjects wore nasal cannulae, the g-inch adapter was fitted with a nasal catheter threaded through the nasal passage to a point just above the epiglottis, so that gas coming through the cannula and entrained room air could mix completely. monary disease (COPD), and the tenth patient was treated at home and had hypoxemia second to COPD. Two other subjects were normal volunteers.
Analysis of arterial blood gas levels in the first group of three patients was performed before therapy was begun and after one hour of therapy.
In the second group of three patients, arterial blood gas levels were determined before therapy was begun, after 30 minutes of therapy via nasal cannulae, and after one hour of therapy via a selected Venturi mask. In the third group of three patients, arterial bloodgaslevels were determined beforetherapywas begun and at 6, 12, and 40 hours after therapy was begun. The patient treated at home received the same F1o2 as was administered to her in the hospital using a pipeline oxygen source. The concentration of oxygen delivered by the en richer was checked by periodic and regular oxygen analysis in visits to the home up to 2,000 hours of operating time. All determinations of arterial blood gas levels were performed with an automated blood gas analyzer (Radiometer ABL 1). 
RESULTS
It was demonstrated in the laboratory that the concentration ofoxygen delivered by theenricher is inversely related to flow; ie, the concentration of oxygen was highest at low flows and lowest at high flows (Fig 3) .The additionof a bubble humidifier and any further resistances to flow (nasal cannula or oxygen connectingtubing) caused a slightdiffer ence between the concentration measured by the enricher (internal fuel cell) and the externally mea sured concentration of oxygen at the humidifier's outlet, the end of the connecting tubing, or the tip of the cannula, with the concentration measured at the enricher beinghigherby 1 to2 percent. using100 percentoxygen asthesourcegas,inwhich the concentration of oxygen holds stable over a rangeofflowrates(4 to8 Llmin). from the enricher. This variation increasedas the flow rate from the enricher increased. Thus, the mean valuesfor inhaledoxygen concentration de pended on the flow rate from the enricher and the subject's breathing pattern, with the concentration of oxygen ranging from 22 to 44 percent (Fig 6) .
Tables1 to3 show the arterial blood gas levels in our three groups of patients. Note that in Table 1 , valuesforarterial oxygen tension(PaOa) after ther apy were consistent with what we might expect from nasalcannulaepowered by 100 percentoxy gen. In Table 2 , the rise in PaOi is progressive and consistent with a concomitantriseinF1o2.In Table  3 , values for Pa02 were rather steady over the dura tion of the test (40 hours). Over a 2,000-hour period the oxygen concentration delivered by the enricher remained stable on the patient receiving care at home.
Discussiox
Treatment of the hypoxemic patient at home, whether the cause is COPD, pulmonary fibrosis, or congestive heart failure, has heretofore been limited to the use of oxygen cylinders(gas) or â€oe¿ boilersâ€• (liquid) @ The development of oxygen enrichers ensuresa constant, readily available supplyof oxy gen without the problems of immobility, changing cylinders, relyingon contractors, running low on oxygen, or leakage. The necessity for the use of oxy gen athome isstill controversial4 and isoutsidethe scope of this report; however, several reports attest to an improvement in activity, cardiacstatus, blood volume, and pulmonary capacityduring prolonged use.3'5'7
The enricher's features ofdurability, reproducibil ity,accuracy,and proper use with nasalcannulae and Venturimasks are exemplified in thisstudy.It has been demonstratedthatwith specific flow rates (Fig 4) , a specific manufacturer's Venturi masks may be used; and with properly selected patients, nasal cannulae may be used for an appropriate re sponse. It must be pointed out that with Venturi masks thetotal outflowofgastothepatient, because of the rather specific flow rates from the source that are used, may not â€oe¿ coverâ€• the patient's peak inspira tory demand. This may cause him to entrainam bient air from around the mask, thus lowering the F1o2. Furthermore, the machine requires electrical power, and the costofelectricity and thepossibility of brownouts or blackoutshave to be considered. Clearly, a backup supplyofgasmust be provided.
In any case, the proper F1o2 to be delivered to the patientreceiving careat home must be established in the hospital. As with typesof care at home, the patient must be instructed in the use and care of the machine; and, most important, the patient should be regularly reevaluated to determine if the enricher produced concentration of oxygen and flowrateare appropriate. 
